Carregant...
Effects of Glycyrrhetic Acid on Human Chronic Myelogenous Leukemia Cells
OBJECTIVES: Chronic myelogenous leukemia (CML) is a type of blood cancer that is initially treated with imatinib (first Abl kinase inhibitor). However, some patients with CML develop imatinib resistance. Several new generation drugs have been developed, but do not overcome this problem. Glycyrrhetic...
Guardat en:
| Publicat a: | Turk J Pharm Sci |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Galenos Publishing
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227864/ https://ncbi.nlm.nih.gov/pubmed/32454760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjps.galenos.2018.49389 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|